Emerging evidence suggests the new class of weight loss medications like semaglutide and tirzepatide (best known by brand name medications like Ozempic and Zepbound) might help people with substance use disorder by reducing the desire to use alcohol and other drugs
Always confirm your specific plan rules with your human resources or benefits administrator to avoid forfeiting eligible funds
Bi bn cht ca m whey l cung cp cht dinh dng cn thit cho c th, c bit l ngun protein tinh khit, khng cha tp cht, cht bo v ng sa
Depending on what l eat, I sometimes experience bloating, nausea, and very loose bowel movements for a few days
Special Precautions: For Pregnancy and Breast-Feeding: Pregnant and lactating mothers should not take any single supplement in higher-than-normal doses unless recommended by a health-care provider for a special condition
| Medication | Receptor Targets | Peak Weight Loss (Trials) | Wyoming 503A Access | |---|---|---|---| | Semaglutide 2.4 mg | GLP-1 | 14.9% at 68 wk (STEP-1) [2] | Yes | | Tirzepatide 15 mg | GIP + GLP-1 | 20.9% at 72 wk (SURMOUNT-1) [3] | Yes | | Retatrutide 12 mg | GIP + GLP-1 + Glucagon | 24.2% at 48 wk (Phase 2) [1] | Yes | The 24.2% result for retatrutide came at 48 weeks, a shorter trial duration than STEP-1 (68 weeks) or SURMOUNT-1 (72 weeks)
